Oha-Medsp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-06-09
Share capital
5,000.00 PLN
Registered address
ul. Wolność 2/5u-80, 01-018 Warszawa, Poland
Electronic delivery address
AE:PL-49828-74042-JGVAF-15

Financials

Revenue history (in k)

From the notes

Foreign sales66.35% of revenue ($224,175)
Contingent liabilities$0

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 17 days for 2021).

  • 202503/07/2026
  • 202424/06/2025
  • 202316/07/2024
  • 202212/07/2023
  • 202101/08/2022
  • 202025/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 35%
Top 32%
City · Warszawa25,449 / 56,967
Top 45%
Voivodeship · Mazowieckie35,498 / 77,130
Top 46%
Country · Poland141,347 / 297,932
Top 47%

Results vs industry

Revenue
This companyUSD 337.90kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD 101.12kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 229.63kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 238.91kMedianUSD 278.35kAverageUSD 8.47m

Authorized Representatives

Honorata Ewa Pojmańskaage 37 – President of the Management Board
Olga Teresa Witkowskaage 46 – Attorney-in-fact (sole)

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
33$445.7133%
33$445.7133%
34$459.2134%

Agnieszka Małgorzata Pojmańska and Honorata Ewa Pojmańska hold a combined 66% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-08-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies
$372
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$33

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Lymelab Pharma sp. z o.o.sp. k.
Oasis DiagnosticsS.A.
NanosanguisS.A.
Codeit4us Rndsp. z o.o.
VB IdeaP.S.A.
NanovelosS.A.
Bio2materialssp. z o.o.
Nanostalsp. z o.o.
IncellvuS.A.
NanotheaS.A.

FAQ

Last updated: 2026-07-06